Indexé dans
  • Ouvrir la porte J
  • Genamics JournalSeek
  • Clés académiques
  • JournalTOCs
  • CiteFactor
  • Répertoire des périodiques d'Ulrich
  • Accès à la recherche mondiale en ligne sur l'agriculture (AGORA)
  • Bibliothèque des revues électroniques
  • Centre international pour l'agriculture et les biosciences (CABI)
  • RechercheRef
  • Répertoire d'indexation des revues de recherche (DRJI)
  • Université Hamdard
  • EBSCO AZ
  • OCLC - WorldCat
  • érudit
  • Catalogue en ligne SWB
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publions
  • Fondation genevoise pour la formation et la recherche médicales
  • Pub européen
  • Google Scholar
Partager cette page
Dépliant de journal
Flyer image

Abstrait

Antimicrobial Activity of Leaf Extracts of Tinospora cordifolia (Thunb) Miers

Amina Tariq*, Ayesha Kiran, Sumera Javad, Kiran Shehzad

The purpose of present work was to check the Antibacterial activity of different extracts of Tinospora cordifolia. Antibacterial activity of plant extract was checked against different bacterial species by using agar well diffusion method. Bacterial strains used were Pseudomonas aeruginosa, Bacillus sp. and Brucella sp. Maximum zone of inhibition observed in Methanol+Augmenton was (30.14 mm) against Bacillus sp. rather than Pseudomonas aeruginosa and Brucella sp. (29.04 mm and 25.21 mm) respectively. Maximum zone of inhibition observed in Ethyl acetate+Augmenton was (42.10 mm) against Pseudomonas aeruginosa rather than Bacillus sp. (25.96 mm) respectively. Zone of inhibition observed in n-Hexane+Augmenton was almost same against Pseudomonas aeruginosa and Bacillus sp. (40.10 mm and 40.17 mm) respectively. Results showed that Ethyl acetate extract in combination with antibiotic increased the efficiency of antibiotic against Pseudomonas aeruginosa while methanol in combination with antibiotic increased the efficiency of antibiotic against Bacillus sp. Tinospora cordifolia used for the treatment of various infectious diseases and to use the Tinospora cordifolia extracts for commercial level augmentation of antibiotic to produce new antibiotics.